GO
Loading...
 

Eli Lilly's CEO on Prescription for Profits

Wed 25 Apr 12 | 07:10 AM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Eli Lilly's CEO on Prescription for Profits

Wed 25 Apr 12 | 07:10 AM ET
John Lechleiter, Eli Lilly chairman & CEO breaks down his company's earnings results of an adjusted $0.92 a share versus estimates of $0.78 est. and a look at the drug maker's generic challenges, and the politics of prescriptions.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Why this expert still prefers DMs over EMs
Mon 21 Apr 14 | 12:02 AM ET
Latest Videos
UBS: See 8% growth for US earnings this year
Sun 20 Apr 14 | 11:08 PM ET
Latest Videos
See dollar-yen at 110 in long-term: Macquarie
Sun 20 Apr 14 | 10:47 PM ET
Latest Videos
China-made vehicles have high quality: IHS
Sun 20 Apr 14 | 10:39 PM ET
Go
Displaying results for: Latest Video | US